NPI: 1306225222 · RAPID CITY, SD 57702 · Urgent Care Clinic/Center · NPI assigned 05/26/2015
Authorized official PIERCE, JOHN controls 18+ related entities in our dataset. Read more
| Authorized Official | PIERCE, JOHN (PRESIDENT MONUMENT HEALTH) |
| NPI Enumeration Date | 05/26/2015 |
Other providers sharing the same authorized official: PIERCE, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 265 | $7K |
| 2019 | 487 | $11K |
| 2020 | 833 | $12K |
| 2021 | 2,822 | $71K |
| 2022 | 1,932 | $56K |
| 2023 | 1,671 | $56K |
| 2024 | 2,207 | $101K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,954 | 3,351 | $143K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 2,015 | 1,835 | $33K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 480 | 434 | $28K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 434 | 388 | $26K |
| 0240U | 170 | 155 | $17K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 298 | 285 | $13K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 104 | 100 | $12K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 317 | 281 | $9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 109 | 103 | $7K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 320 | 134 | $4K |
| 36415 | Collection of venous blood by venipuncture | 437 | 390 | $3K |
| 0001A | 69 | 69 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 112 | 105 | $2K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 207 | 176 | $2K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 60 | 50 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 13 | 13 | $2K |
| 0002A | 49 | 49 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 171 | 153 | $1K |
| 0071A | 37 | 33 | $1K | |
| 71046 | Radiologic examination, chest; 2 views | 56 | 51 | $1K |
| 80053 | Comprehensive metabolic panel | 72 | 67 | $707.52 |
| 0072A | 18 | 18 | $674.39 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 15 | 12 | $362.67 |
| 81003 | 164 | 147 | $312.75 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 14 | 13 | $172.61 |
| 91300 | 127 | 117 | $0.00 | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 321 | 315 | $0.00 |
| 91307 | 74 | 58 | $0.00 |